PNC Financial Services Group’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-44,769
Closed -$6.27M 4244
2018
Q4
$6.27M Sell
44,769
-3,943
-8% -$599K 0.01% 611
2018
Q3
$8.32M Sell
48,712
-1,212
-2% -$204K 0.01% 593
2018
Q2
$8.66M Buy
49,924
+35,706
+251% +$5.37M 0.01% 579
2018
Q1
$1.64M Buy
14,218
+60
+0.4% +$6.38K ﹤0.01% 1102
2017
Q4
$1.19M Buy
+14,158
New +$1.18M ﹤0.01% 1239
2017
Q3
Sell
-200
Closed -$16K 4303
2017
Q2
$16K Buy
+200
New +$11.1K ﹤0.01% 3419

Other funds holding LOXO

PNC Financial Services Group's LOXO Position: Q1 2019 in Review

PNC Financial Services Group sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 44,769 shares — an estimated $6.27M sold.

PNC Financial Services Group first reported a position in LOXO in Q2 2017 and held it in 6 quarters. The position peaked at $8.66M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • PNC Financial Services Group reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • PNC Financial Services Group sold 44,769 Loxo Oncology, Inc shares in Q1 2019, an estimated $6.27M.
  • PNC Financial Services Group first reported a position in Loxo Oncology, Inc in Q2 2017 and held it in 6 quarters.
  • PNC Financial Services Group's Loxo Oncology, Inc position peaked at $8.66M in Q2 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on PNC Financial Services Group's 13F filing for Q1 2019, filed 10 May 2019.